ClinicalTrialsFinder

Gastroesophageal-junction Cancer Clinical Trials in Porto Alegre, Rio Grande do Sul

1 recruitingPorto Alegre, Rio Grande do Sul, Brazil

Showing 1–1 of 1 trials

Recruiting
Phase 3

A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer

Gastric CancerGastroesophageal-junction CancerHER2-positive Gastric Cancer+1 more
Shanghai Henlius Biotech550 enrolled208 locationsNCT06532006